Evaluating Patient-Based Outcome Measures - NIHR Health ...

62
References
Tarlov AR, Ware J, Greenfield S, Nelson EC, Perrin E,
Zubkoff M (1989). The Medical Outcomes Study. An
application of methods for monitoring the results of
medical care. JAMA;262:925–30.
Taylor KM, Macdonald KG, Bezjak A, Ng P, DePetrillo AD
(1996). Physicians’ perspective on quality of life: an
exploratory study of oncologists. Qual Life Res;5:5–14.
Tennant A, Hillman M, Fear J, Pickering A,
Chamberlain MA (1996). Are we making the most of
the Stanford Health Assessment Questionnaire? Br J
Rheumatol;35:574–8.
Testa MA, Anderson RB, Nackley JF, Hollenberg NK
(1993). Quality of life and antihypertensive therapy in
men. A comparison of captopril with enalapril. The
Quality-of-Life Hypertension Study Group. N Engl J
Med;328:907–13.
Testa MA, Simonson DC (1996). Assessment of quality-oflife
outcomes. N Engl J Med;334:835–40.
The EuroQol Group (1992). EuroQol – a reply and
reminder. Health Policy;20:329–32.
Till JE, Sutherland HJ, Meslin EM (1992). Is there a role
for preference assessments in research on quality of life
in oncology? Qual Life Res;1:31–40.
Till JE, Osoba D, Pater JL, Young JR (1994). Research on
health-related quality of life: dissemination into practical
applications. Qual Life Res;3:279–83.
Torrance GW (1973). Health index and utility models:
some thorny issues. Health Serv Res;8:12–14.
Torrance GW (1986). Measurement of health state
utilities for economic appraisal: a review. J Health
Econ;5:1–30.
Torrance GW (1987). Utility approach to measuring
health-related quality of life. J Chronic Dis;40:593–603.
Torrance GW (1995). An interview on utility
measurement [interview by Bernie O’Brien].
J Rheumatol;22:1200–2.
Torrance GW, Furlong W, Feeny DH, Boyle M (1995).
Multi-attribute preference functions: Health Utilities
Index. PharmacoEconomics;7:503–20.
Tugwell P, Bombardier C (1982). A methodologic
framework for developing and selecting endpoints in
clinical trials. J Rheumatol;9:758–62.
Tugwell P, Bombardier C, Buchanan WW, Goldsmith
CH, Grace E, Hanna B (1987). The MACTAR Patient
Preference Disability Questionnaire – an individualized
functional priority approach for assessing improvement
in physical disability in clinical trials in rheumatoid
arthritis. J Rheumatol;14:446–51.
Tugwell P, Bombardier C, Buchanan WW, Goldsmith
CH, Grace E, Bennett K, et al (1990). Methotrexate in
rheumatoid arthritis. Impact on quality of life assessed
by traditional standard-item and individualized patient
preference health status questionnaires. Arch Intern
Med;150:59–62.
Tugwell P, Bombardier C, Bell M, Bennett K, Bensen W,
Grace E, et al (1991). Current quality-of-life research
challenges in arthritis relevant to the issue of clinical
significance. Control Clin Trials;12:217S–225S.
Tuley MR, Mulrow CD, McMahan CA (1991). Estimating
and testing an index of responsiveness and the relationship
of the index to power. J Clin Epidemiol;44:417–21.
van Alphen A, Halfens R, Hasman A, Imbos T (1994).
Likert or Rasch? Nothing is more applicable than good
theory. J Adv Nurs;20:196–201.
van Knippenberg FC, de Haes JC (1988). Measuring the
quality of life of cancer patients: psychometric properties
of instruments. J Clin Epidemiol;41:1043–53.
van Praag B (1993). The relativity of the welfare concept.
In: The quality of life (Nussbaum M, Sen A, editors).
Oxford: Clarendon Press. p. 362–85.
Veldhuyzen van Zanten SJ (1991). Quality of life as
outcome measures in randomized clinical trials. An
overview of three general medical journals. Control Clin
Trials;12:234S–242S.
Ventegodt S (1996). Measuring the quality of life.
Copenhagen: Forskningcentrets Forlag.
Visser MC, Fletcher AE, Parr G, Simpson A, Bulpitt CJ
(1994). A comparison of three quality of life instruments
in subjects with angina pectoris: the Sickness Impact
Profile, the Nottingham Health Profile and the Quality
of Well Being Scale. J Clin Epidemiol;47:157–63.
von Neumann J, Morgernstern O (1953). The theory of
games and economic behaviour. 3rd edn. Princeton:
Princeton University Press.
Wade DT (1988). Measurement in rehabilitation.
Age Ageing;17:289–92.
Wade DT (1992). Measurement in neurological
rehabilitation. Oxford: Oxford University Press.
Ware J (1984). Methodological considerations in the
selection of health status assessment procedures. In:
Assessment of quality of life in clinical trials of cardiovascular
therapies (Wenger NK, Mattson ME, Furberg
CD, Elinson J, editors). New York: LeJacq Publishing Inc.
p. 87–111.
Ware J (1987). Standards for validating health measures:
definition and content. J Chronic Dis;40:473–80.
Ware J (1995). The status of health assessment 1994.
Ann Rev Public Health;16:327–54.
Ware J, Sherbourne CD (1992). The MOS 36-item shortform
health survey (SF–36). I. Conceptual framework
and item selection. Med Care;30:473–83.
Ware J, Brook RH, Davies AR, Lohr KN (1981). Choosing
measures of health status for individuals in general
populations. Am J Public Health;71:620–5.
Ware J, Kosinski M, Bayliss MS, McHorney CA, Rogers
WH, Raczek A (1995). Comparison of methods for the
scoring and statistical analysis of SF-36 health profile and
summary measures: summary of results from the Medical
Outcomes Study. Med Care;33:AS264–79.